We have located links that may give you full text access.
Journal Article
Review
Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy.
Urothelial cancer (UC) represents one of the most frequent malignancies, which causes about 150,000 deaths per year worldwide. To date, only a few chemotherapeutic drugs have been approved against UC, showing poor results, and limited effective molecular markers. In the last years, several studies have evaluated the correlation between bladder cancer and phlogosis, showing that some cytokines produced by different stimuli can enhance invasion and migration of tumor cells. In more recent years, antibodies blocking immune checkpoints have exhibited oncologic efficacy, including increased overall survival, in various tumor types. To date, several studies evaluated the role of immune-checkpoint inhibitors in metastatic UC showing exiting results, compared to those of classic chemotherapeutic regimens. In this review, we summarized data on inflammatory mediators and discussed implications for treatment with new immune-related drugs in UC patients.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app